Pharmaco-metabonomic phenotyping and personalized drug treatment

Cited by (747)

Items 201–300 of 747

1. Recent advances in metabolomics in neurological disease, and future perspectives
   Aihua Zhang, Hui Juan Sun, Xijun Wang · 2013 · Analytical and Bioanalytical Chemistry
2. Metabolomics and the Microbiome as Biomarkers in Sepsis.
   Jisoo Lee, D. Banerjee · 2020 · Critical care clinics
3. Comparison of Metabolomics Approaches for Evaluating the Variability of Complex Botanical Preparations: Green Tea ( Camellia sinensis ) as a Case Study
   Joshua J. Kellogg, Tyler N. Graf, Mary F. Paine, Jeannine S. McCune, Olav M. Kvalheim, Nicholas H. Oberlies, Nadja B. Cech · 2017 · Journal of Natural Products
4. The Time Is Right to Focus on Model Organism Metabolomes
   Arthur S. Edison, Robert D. Hall, Christophe Junot, Peter D. Karp, Irwin J. Kurland, Robert Mistrík, Laura K Reed, Kazuki Saito, Reza M. Salek, Christoph Steinbeck et al. · 2016 · Metabolites
5. Pattern recognition analysis for hepatotoxicity induced by acetaminophen using plasma and urinary 1H NMR-based metabolomics in humans.
   Ji Won Kim, S. Ryu, Siwon Kim, H. Lee, M. Lim, S. Seong, Suhkmann Kim, Y. Yoon, Kyu-Bong Kim · 2013 · Analytical Chemistry
6. Using metabolomic analysis to understand inflammatory bowel diseases
   Hui‐Ming Lin, Nuala Ann Helsby, Daryl D. Rowan, Lynnette Robyn Ferguson · 2010 · Inflammatory Bowel Diseases
7. Systems biology and functional genomics approaches for the identification of cellular responses to drug toxicity
   A. Harrill, I. Rusyn · 2008 · Expert Opinion on Drug Metabolism & Toxicology
8. Potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic tool
   M. Ala-Korpela · 2007 · Expert Review of Molecular Diagnostics
9. The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
   Arwa M. Amin, Lim Sheau Chin, Dzul Azri Mohamed Noor, Muhamad Ali SK Abdul Kader, Kah Hay Yuen, Baharudin Ibrahim · 2017 · Cardiology Research and Practice
10. Omics and its potential impact on R&D and regulation of complex herbal products
    Olavi Pelkonen, Markku Pasanen, John C. Lindon, Kelvin Chan, Liping Zhao, Greer Deal, Qihe Xu, Tai‐Ping Fan · 2012 · Journal of Ethnopharmacology
11. Metabolomics: A New Frontier for Research in Pediatrics
    Silvia Carraro, Giuseppe Giordano, Fabiano Reniero, Giorgio Perilongo, Eugenio Baraldi · 2009 · The Journal of Pediatrics
12. Gut microbiome modulates the toxicity of hydrazine: a metabonomic study.
    J. Swann, Yu-Lan Wang, L. Abecia, A. Costabile, K. Tuohy, G. Gibson, David Roberts, J. Sidaway, H. Jones, I. Wilson et al. · 2009 · Molecular Biosystems
13. Genome‐level analysis of genetic regulation of liver gene expression networks
    Daniel M. Gatti, A. Maki, E. Chesler, R. Kirova, O. Kosyk, Lu Lu, K. Manly, Robert W. Williams, A. Perkins, M. A. Langston et al. · 2007 · Hepatology
14. Pharmacometabonomics: data processing and statistical analysis
    Jianbo Fu, Ying Zhang, Jin Liu, Xichen Lian, Jing Tang, Feng Zhu · 2021 · Briefings in Bioinformatics
15. Identification of biomarkers to diagnose diseases and find adverse drug reactions by metabolomics
    Daisuke Saigusa, Naomi Matsukawa, Eiji Hishinuma, S. Koshiba · 2020 · Drug Metabolism and Pharmacokinetics
16. Metabotyping and its application in targeted nutrition: an overview
    Anna Riedl, Christian Gieger, Hans Hauner, Hannelore Daniel, Jakob Linseisen · 2017 · British Journal Of Nutrition
17. From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized Medicine
    Jeremy Ramsey Everett · 2016 · Frontiers in Pharmacology
18. Biomarkers of primary dysmenorrhea and herbal formula intervention: an exploratory metabonomics study of blood plasma and urine.
    Pei Liu, Jin-Ao Duan, Pei-Juan Wang, Da-Wei Qian, Jian-Ming Guo, E. Shang, S. Su, Yu-Ping Tang, Zong-Xiang Tang · 2013 · Molecular Biosystems
19. Metabolome 2.0: quantitative genetics and network biology of metabolic phenotypes
    Marc‐Emmanuel Dumas · 2012 · Molecular BioSystems
20. Angiotensin-converting enzyme inhibitor-related angioedema: how to deal with it
    L. Beltrami, Lorenza Chiara Zingale, Stefano Carugo, Marco Cicardi · 2006 · Expert Opinion on Drug Safety
21. Metabolomic high-content nuclear magnetic resonance-based drug screening of a kinase inhibitor library
    Tiziani, Stefano, Kang, Yunyi, Choi, Janet S., Roberts, William, Paternostro, Giovanni · 2011 · Nature Communications
22. Pharmacometabolomics Reveals That Serotonin Is Implicated in Aspirin Response Variability
    Sandrine Ellero‐Simatos, Joshua P. Lewis, Anastasia Georgiades, L.M. Yerges-Armstrong, AL Beitelshees, Richard B. Horenstein, Adriaan D. Dane, Amy C. Harms, Raymond Ramaker, Rob J. Vreeken et al. · 2014 · CPT Pharmacometrics & Systems Pharmacology
23. Multinuclear nanoliter one-dimensional and two-dimensional NMR spectroscopy with a single non-resonant microcoil
    R. Fratila, M. Gomez, S. Sykora, A. Velders · 2014 · Nature Communications
24. Systems Biology Technologies Enable Personalized Traditional Chinese Medicine: A Systematic Review
    Xijun Wang, Aihua Zhang, Hui Juan Sun, Ping Wang · 2012 · The American Journal of Chinese Medicine
25. Applications of metabolomics for understanding the action of peroxisome proliferator-activated receptors (PPARs) in diabetes, obesity and cancer
    Zsuzsanna Ament, Mojgan Masoodi, Julian Leether Griffin · 2012 · Genome Medicine
26. Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy
    Hector C. Keun, Jasmin K. Sidhu, Dmitri Pchejetski, Jacqueline S. Lewis, Helena Marconell, Michael Patterson, Steven Bloom, Vian Amber, R. Charles Coombes, Justin Stebbing · 2009 · Clinical Cancer Research
27. Biomarkers for the Diagnosis and Management of Drug-Induced Liver Injury
    Paul B. Watkins · 2009 · Seminars in liver disease (Print)
28. Development of a Data-Independent Targeted Metabolomics Method for Relative Quantification Using Liquid Chromatography Coupled with Tandem Mass Spectrometry.
    Yan-Hua Chen, Zhi Zhou, Wei Yang, N. Bi, Jing Xu, Jiu-Ming He, Rui-Ping Zhang, Lvhua Wang, Z. Abliz · 2017 · Analytical Chemistry
29. Allostasis and Resilience of the Human Individual Metabolic Phenotype
    Veronica Ghini, Edoardo Saccenti, Leonardo Tenori, Michael Assfalg, Claudio Luchinat · 2015 · Journal of Proteome Research
30. Pharmacometabolomics of l -Carnitine Treatment Response Phenotypes in Patients with Septic Shock
    Michael A. Puskarich, Michael A. Finkel, Alla Karnovsky, Alan E. Jones, Julie Trexel, Brooke N. Harris, Kathleen A. Stringer · 2014 · Annals of the American Thoracic Society
31. Metabolomics as a Key Integrator for “Omic” Advancement of Personalized Medicine and Future Therapies
    Andrea D. Eckhart, Kirk D. Beebe, Mike Milburn · 2012 · Clinical and Translational Science
32. Drug-induced liver injury: a summary of recent advances
    Jonathan G. Stine, James H. Lewis · 2011 · Expert Opinion on Drug Metabolism & Toxicology
33. Comparative metabolomic and ionomic approach for abundant fishes in estuarine environments of Japan
    Seiji Yoshida, Yasuhiro Date, Makiko Akama, J. Kikuchi · 2014 · Scientific Reports
34. Genetics of stroke: a review of recent advances
    Sophie Domingues‐Montanari, Maite Mendióroz, Alberto Del Río-Espínola, Israel Fernández‐Cadenas, Joan Montaner · 2008 · Expert Review of Molecular Diagnostics
35. Application of metabonomics in drug development.
    H. Keun, T. Athersuch · 2007 · Pharmacogenomics (London)
36. Identification of Reliable Components in Multivariate Curve Resolution-Alternating Least Squares (MCR-ALS): a Data-Driven Approach across Metabolic Processes
    Hiromi Motegi, Yuuri Tsuboi, Ayako Saga, Tomoko Kagami, Maki Inoue, Hideaki Toki, Osamu Minowa, Tetsuo Noda, Jun Kikuchi · 2015 · Scientific Reports
37. Characterization of tea cultivated at four different altitudes using 1H NMR analysis coupled with multivariate statistics.
    Akiko Ohno, K. Oka, Chiseko Sakuma, H. Okuda, K. Fukuhara · 2011 · Journal of Agricultural and Food Chemistry
38. Navigating the Human Metabolome for Biomarker Identification and Design of Pharmaceutical Molecules
    I. Kouskoumvekaki, G. Panagiotou · 2010 · Journal of Biomedicine and Biotechnology
39. Promises of Biomarkers in Drug Development – A Reality Check
    E. Marrer, F. Dieterle · 2007 · Chemical Biology and Drug Design
40. The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease
    Jonathan Philip Segal, Benjamin Harvey Mullish, Mohammed Nabil Quraishi, Animesh Acharjee, Horace R. T. Williams, Tariq H Iqbal, Ailsa L Hart, Julian Roberto Marchesi · 2019 · Therapeutic Advances in Gastroenterology
41. Whole-body systems approaches for gut microbiota-targeted, preventive healthcare
    Liping Zhao, Jian Shen · 2010 · Journal of Biotechnology
42. Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug–microbiome interactions
    Ramy Karam Aziz, Shaimaa M. Hegazy, Reem Yasser, Mariam R. Rizkallah, Marwa Tarek ElRakaiby · 2018 · Expert Opinion on Drug Metabolism & Toxicology
43. Metabolomics: moving towards personalized medicine
    E. Baraldi, S. Carraro, G. Giordano, F. Reniero, G. Perilongo, F. Zacchello · 2009 · Italian Journal of Pediatrics
44. Quantitative two‐dimensional HRMAS 1H‐NMR spectroscopy‐based metabolite profiling of human cancer cell lines and response to chemotherapy
    Mathilde Bayet‐Robert, Dominique Loiseau, Pascale G. Rio, Aïcha Demidem, Chantal Barthomeuf, Georges Stepien, Daniel Morvan · 2010 · Magnetic Resonance in Medicine
45. Pharmacokinetic and pharmacometabolomic study of pirfenidone in normal mouse tissues using high mass resolution MALDI-FTICR-mass spectrometry imaging
    N. Sun, I. Fernandez, Mian Wei, Yin Wu, M. Aichler, O. Eickelberg, A. Walch · 2015 · Histochemistry and Cell Biology
46. Stable Isotope-Labeled Tracers for Metabolic Pathway Elucidation by GC-MS and FT-MS
    Richard M. Higashi, Teresa W.‐M. Fan, Pawel Konrad Lorkiewicz, Hunter Moseley, Andrew N. Lane · 2014 · Methods in molecular biology
47. Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach
    Wanping Aw, Shinji Fukuda · 2014 · Seminars in Immunopathology
48. Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach
    Hyuk Nam Kwon, Mina K. Kim, He Wen, Sunmi Kang, Hye-ji Yang, Myung-Joo Choi, Hee Seung Lee, Dalwoong Choi, In Suh Park, Young Ju Suh et al. · 2010 · Kidney International
49. Serum metabolome and targeted bile acid profiling reveals potential novel biomarkers for drug-induced liver injury
    Zhenhua Ma, Xiaomei Wang, Peiyuan Yin, Ruihong Wu, Lina Zhou, Guowang Xu, Junqi Niu · 2019 · Medicine
50. Development of Blood Biomarkers for Drug-Induced Liver Injury: An Evaluation of Their Potential for Risk Assessment and Diagnostics
    David E. Amacher, Shelli Schomaker, Jiri Aubrecht · 2013 · Molecular Diagnosis & Therapy
51. Matrix Metalloproteinase-9 is a Diagnostic Marker of Heterotopic Ossification in a Murine Model
    Eric J. Rodenberg, Ali Azhdarinia, ZaWaunyka W. Lazard, Mary A. Hall, Sun Kuk Kwon, Nathaniel L. Wilganowski, Elizabeth A. Salisbury, Maria Merched-Sauvage, Elizabeth A. Olmsted‐Davis, Eva Marie Sevick-Muraca et al. · 2011 · Tissue Engineering Part A
52. Evaluation and Characterization of Bacterial Metabolic Dynamics with a Novel Profiling Technique, Real-Time Metabolotyping
    Shinji Fukuda, Yumiko Nakanishi, Eisuke Chikayama, Hiroshi Ohno, Tsuneo Hino, Jun Kikuchi · 2009 · PLoS ONE
53. Ratio Analysis NMR Spectroscopy (RANSY) for Selective Metabolite Identification in Complex Samples
    Siwei Wei, Jian Zhang, Lingyan Liu, T. Ye, G. A. Nagana Gowda, Fariba Tayyari, D. Raftery · 2011 · Analytical Chemistry
54. Metabolomic analysis of human disease and its application to the eye
    Stephen P. Young, Graham R. Wallace · 2009 · Journal of ocular biology, diseases, and informatics
55. First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform.
    Jun Cao, Yi-Jun Mi, Cui-Lin Shi, Yi-Cong Bian, Chen-Rong Huang, Zhi-Jian Ye, Lin-Sheng Liu, L. Miao · 2018 · Biochemical and Biophysical Research Communications - BBRC
56. Pharmacometabolomics in Early‐Phase Clinical Development
    Tal Burt, Savita Nandal · 2016 · Clinical and Translational Science
57. The application of microbore UPLC/oa-TOF-MS and 1H NMR spectroscopy to the metabonomic analysis of rat urine following the intravenous administration of pravastatin.
    E. Lenz, Rebecca E. Williams, J. Sidaway, Brian W. Smith, R. Plumb, Kelly A. Johnson, P. Rainville, J. Shockcor, C. Stumpf, Jennifer H. Granger et al. · 2007 · Journal of Pharmaceutical and Biomedical Analysis
58. Intracellular metabolite profiling of platelets: evaluation of extraction processes and chromatographic strategies.
    G. Paglia, M. Magnúsdóttir, S. Thorlacius, Ó. Sigurjónsson, S. Guðmundsson, B. Palsson, I. Thiele · 2012 · Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
59. Identification of Possible Salivary Metabolic Biomarkers and Altered Metabolic Pathways in South American Patients Diagnosed with Oral Squamous Cell Carcinoma
    Mariana de Sá Alves, Nayara de Sá Rodrigues, Celso Müller Bandeira, José Francisco Sales Chagas, Maria Beatriz Nogueira Pascoal, Gabrielle Luana Jimenez Teodoro Nepomuceno, Herculano da Silva Martinho, Mônica Ghislaine Oliveira Alves, Maria Anita Mendes, Meriellen Dias et al. · 2021 · Metabolites
60. Advanced mass spectrometry-based multi-omics technologies for exploring the pathogenesis of hepatocellular carcinoma.
    Wen-Na Nie, Leyu Yan, Yie-Hou Lee, C. Guha, I. Kurland, Haitao Lu · 2016 · Mass spectrometry reviews (Print)
61. Noninvasive analysis of metabolic changes following nutrient input into diverse fish species, as investigated by metabolic and microbial profiling approaches
    Taiga Asakura, K. Sakata, Seiji Yoshida, Yasuhiro Date, J. Kikuchi · 2014 · PeerJ
62. Magnetic Resonance Spectroscopy Detectable Metabolomic Fingerprint of Response to Antineoplastic Treatment
    Alessia Lodi, Sabrina M. Ronen · 2011 · PLoS ONE
63. Effects of Valproic Acid on Organic Acid Metabolism in Children: A Metabolic Profiling Study
    Kris Price, R. Pearce, U. Garg, B. A. Heese, Laurie D. Smith, J. Sullivan, M. J. Kennedy, J. Bale, Robert M. Ward, T. Chang et al. · 2011 · Clinical pharmacology and therapy
64. Pharmacogenomics of anticoagulants: steps toward personal dosage
    Ann K. Daly · 2009 · Genome Medicine
65. Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st Century
    Laura K. Schnackenberg · 2007 · Expert Review of Molecular Diagnostics
66. Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics.
    D. Nebert, E. Vesell · 2006 · TIPS - Trends in Pharmacological Sciences
67. Fingerprinting and profiling in metabolomics of biosamples
    Veronica Ghini, Gaia Meoni, Alessia Vignoli, Francesca Di Cesare, Leonardo Tenori, Paola Turano, Claudio Luchinat · 2023 · Progress in Nuclear Magnetic Resonance Spectroscopy
68. Metabolic phenotyping applied to pre-clinical and clinical studies of acetaminophen metabolism and hepatotoxicity
    Muireann Coen · 2015 · Drug metabolism reviews (Softcover ed.)
69. New initiatives for pharmacovigilance in South Korea: introducing the Korea Institute of Drug Safety and Risk Management (KIDS)
    Ju‐Young Shin, Sun-Young Jung, So-Hyeon Ahn, Shin Haeng Lee, Su-Jin Kim, Jong-Mi Seong, Soo-Youn Chung, Byung‐Joo Park · 2014 · Pharmacoepidemiology and Drug Safety
70. Session 2: Personalised nutrition Metabolomic applications in nutritional research
    L. Brennan · 2008 · Proceedings of the Nutrition Society
71. MASS SPECTROMETRY‐BASED PERSONALIZED DRUG THERAPY
    Jiajia Cui, Lei‐Yun Wang, Zhi‐Rong Tan, Hong‐Hao Zhou, Xianquan Zhan, Ji‐Ye Yin · 2020 · Mass Spectrometry Reviews
72. Pharmacometabolomic prediction of individual differences of gastrointestinal toxicity complicating myelosuppression in rats induced by irinotecan
    Yi-qiao Gao, Wei Li, Jiaqing Chen, Xu Wang, Yingtong Lv, Yin Huang, Zun-Jian Zhang, Feng-Guo Xu · 2018 · Acta Pharmaceutica Sinica B
73. A New Paradigm for Known Metabolite Identification in Metabonomics/Metabolomics: Metabolite Identification Efficiency
    Jeremy Ramsey Everett · 2015 · Computational and Structural Biotechnology Journal
74. Metabolic Profiling and Phenotyping of Central Nervous System Diseases: Metabolites Bring Insights into Brain Dysfunctions
    Marc‐Emmanuel Dumas, Laëtitia Davidovic · 2015 · Journal of Neuroimmune Pharmacology
75. Application of metabolomics in viral pneumonia treatment with traditional Chinese medicine
    Lili Lin, Hua Yan, Jiabin Chen, Huihui Xie, Linxiu Peng, Tong Xie, Xia Zhao, Shouchuan Wang, Jinjun Shan · 2019 · Chinese Medicine
76. Investigation of Host–Gut Microbiota Modulation of Therapeutic Outcome
    Lian Yee Yip, Eric Chun Yong Chan · 2015 · Drug Metabolism and Disposition
77. Metabonomic Profiling of Bladder Cancer
    Eric Chun Yong Chan, Kishore Kumar Pasikanti, Yanjun Hong, Paul C. Ho, Ratha Mahendran, Lata Raman Nee Mani, Edmund Chiong, Kesavan Esuvaranathan · 2014 · Journal of Proteome Research
78. Multiplexed Anodic Stripping Voltammetry Detection of Heavy Metals in Water Using Nanocomposites Modified Screen-Printed Electrodes Integrated With a 3D-Printed Flow Cell
    Guo Hua Zhao, Thien‐Toan Tran, Sidharth Modha, Mohammed Sedki, Nosang Vincent Myung, David Jassby, Ashok Mulchandani · 2022 · Frontiers in Chemistry
79. Environmental metabolomics with data science for investigating ecosystem homeostasis
    Jun Kikuchi, Kengo Ito, Yasuhiro Date · 2017 · Progress in Nuclear Magnetic Resonance Spectroscopy
80. Applied metabolomics in drug discovery
    M. Cuperlovic-Culf, Adrian S. Culf · 2016 · Expert Opinion on Drug Discovery
81. Development of a Rapid Microbore Metabolic Profiling Ultraperformance Liquid Chromatography-Mass Spectrometry Approach for High-Throughput Phenotyping Studies.
    N. Gray, Kyrillos N. Adesina-Georgiadis, E. Chekmeneva, R. Plumb, I. Wilson, J. Nicholson · 2016 · Analytical Chemistry
82. Genetic determinants of metabolism in health and disease: from biochemical genetics to genome-wide associations
    Steven L. Robinette, Elaine C. Holmes, Jeremy Kirk Nicholson, Marc‐Emmanuel Dumas · 2012 · Genome Medicine
83. Microbiome: paediatricians’ perspective
    Arora, ShilpaKhanna, Dewan, Pooja, Gupta, Piyush · 2015 · Indian Journal of Medical Research
84. Insights into key aroma of vine tea (Ampelopsis grossedentata) for grade evaluation integrating relative odor activity value, gas chromatography-olfactometry and chemometrics approaches
    Qianqian Li, Bei Li, Chao-Yang Zhang, Xiaoqian Zhou, W. Liu, Yu-Ze Mi, Zuo-Rong Xie, Yi Li, Jian-Xun Li · 2023 · Food Control
85. A Pharmacometabonomic Approach To Predicting Metabolic Phenotypes and Pharmacokinetic Parameters of Atorvastatin in Healthy Volunteers
    Qing Bo Huang, Jiye Aa, Huning Jia, Xiaoqing Xin, Chunlei Tao, Linsheng Liu, Bingjie Zou, Qinxin Song, Jian Shi, Bei Cao et al. · 2015 · Journal of Proteome Research
86. Tumor Growth Prediction with Reaction-Diffusion and Hyperelastic Biomechanical Model by Physiological Data Fusion
    Ken C. L. Wong, R. Summers, E. Kebebew, Jian-Hua Yao · 2015 · Medical Image Anal.
87. Use of EDTA to minimize ionic strength dependent frequency shifts in the 1H NMR spectra of urine
    Vincent Asiago, G. A. Nagana Gowda, Shucha Zhang, Narasimhamurthy Shanaiah, J. Clark, D. Raftery · 2008 · Metabolomics
88. Fecal Metabolomics of Type 2 Diabetic Rats and Treatment with Gardenia jasminoides Ellis Based on Mass Spectrometry Technique
    Yuan Zhou, Lihui Men, Zifeng Pi, Mengying Wei, Fengrui Song, Chunfang Zhao, Zhiqiang Liu · 2018 · Journal of Agricultural and Food Chemistry
89. Metabolomics: Bridging the Gap between Pharmaceutical Development and Population Health
    Vladimir Tolstikov · 2016 · Metabolites
90. Human cellular differences in cAMP ‐ CREB signaling correlate with light‐dependent melatonin suppression and bipolar disorder
    Ludmila Gaspar, Maan van de Werken, A.-S. Johansson, Ermanno Moriggi, Björn Owe‐Larsson, Janwillem W.H. Kocks, Gabriella B. S. Lundkvist, Marijke C. M. Gordijn, Steven A. Brown · 2014 · European Journal of Neuroscience
91. Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure
    Joseph L. McClay, Daniel E. Adkins, Sarah A. Vunck, Angela M. Batman, Robert E. Vann, Shaunna L. Clark, Patrick M. Beardsley, Edwin J. C. G. van den Oord · 2012 · Metabolomics
92. Direct analysis of biological samples using extractive electrospray ionization mass spectrometry (EESI-MS)
    Hai-Wei Gu, N. Xu, Huan-Wen Chen · 2012 · Analytical and Bioanalytical Chemistry
93. Urinary 6β-Hydroxycortisol/Cortisol Ratio Most Highly Correlates With Midazolam Clearance Under Hepatic CYP3A Inhibition and Induction in Females: A Pharmacometabolomics Approach
    Kwang-Hee Shin, Li Young Ahn, Man Ho Choi, Ju-Yeon Moon, Jieon Lee, In‐Jin Jang, Kyung‐Sang Yu, Joo‐Youn Cho · 2016 · The AAPS Journal
94. Prediction of dose-hepatotoxic response in humans based on toxicokinetic/toxicodynamic modeling with or without in vivo data: a case study with acetaminophen.
    A. Péry, C. Brochot, F. Zeman, E. Mombelli, S. Desmots, M. Pavan, E. Fioravanzo, J. Zaldívar · 2013 · Toxicology Letters
95. Community Dynamics in the Mouse Gut Microbiota: A Possible Role for IRF9-Regulated Genes in Community Homeostasis
    Claire L Thompson, Markus J. Hofer, Iain Leslie Campbell, Andrew J. Holmes · 2010 · PLoS ONE
96. Uniform procedure of (1)H NMR analysis of rat urine and toxicometabonomics Part II: comparison of NMR profiles for classification of hepatotoxicity.
    W. G. Schoonen, Cathelijne P. A. M. Kloks, J. Ploemen, M. Smit, P. Zandberg, G. Horbach, J. Mellema, Carol Thijssen-Vanzuylen, A. Tas, J. V. van Nesselrooij et al. · 2007 · Toxicological Sciences
97. Flavoromics Approach in Critical Aroma Compounds Exploration of Peach: Correlation to Origin Based on OAV Combined with Chemometrics
    Qianqian Li, Bei Li, Rong Zhang, Shu-Yan Liu, Shu-Peng Yang, Yi Li, Jian-Xun Li · 2023 · Foods
98. Urinary metabolomic profiling in mice with diet-induced obesity and type 2 diabetes mellitus after treatment with metformin, vildagliptin and their combination
    Helena Pelantová, Martina Bugáňová, Martina Holubová, Blanka Šedivá, Jana Zemenová, David Sýkora, Petra Kaválková, Martin Haluzı́k, Blanka Železná, Lenka Maletı́nská et al. · 2016 · Molecular and Cellular Endocrinology
99. Environmental Chemical Assessment in Clinical Practice: Unveiling the Elephant in the Room
    Nicole Bijlsma, Marc Maurice Cohen · 2016 · International Journal of Environmental Research and Public Health
100. Methods used to increase the comprehensive coverage of urinary and plasma metabolomes by MS.
     Yan-Hua Chen, Jing Xu, Rui-Ping Zhang, Z. Abliz · 2016 · Bioanalysis